…
Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas, Inc. is based in Illinois, Chicago. Ventas, Inc. was incorporated in 1983 in Maryland.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Ventas Inc is a U.S. real estate investment trust that owns healthcare properties such as senior housing, medical office buildings, life-science and hospital assets. It may benefit from aging demographics, growing demand for medical and life-science space and portfolio repositioning that could support steady rental income. Its scale and diversified tenant mix appears positioned to provide income and potential long-term growth.
Key risks include interest-rate sensitivity and leverage, concentrated exposure to senior-housing operators and changes in healthcare reimbursement or regulation that could pressure occupancy, cash flow and property values.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 247.37M | 50.58M | -39.84M | -57.86M | 61.39M |
| Minority interest | -10.14M | -7.20M | -10.68M | 6.52M | 7.55M |
| Net income | 251.38M | 81.15M | -40.97M | -40.93M | 49.01M |
| Selling general administrative | 177.40M | 162.99M | 148.88M | 144.87M | 129.76M |
| Gross profit | -344.22M | 2097.20M | 1936.58M | 1846.28M | 1739.51M |
| Reconciled depreciation | 1411.47M | 1283.29M | 1414.88M | 1197.80M | 1197.40M |
| Ebit | 859.61M | 653.41M | 534.28M | 454.08M | 389.30M |
| Ebitda | 2238.75M | 1936.70M | 1949.15M | 1651.88M | 1604.42M |
| Depreciation and amortization | 1379.14M | 1283.29M | 1414.88M | 1197.80M | 1215.11M |
| Non operating income net other | - | - | - | 8.36M | 278.09M |
| Operating income | 826.81M | 681.23M | 415.51M | 454.08M | 389.30M |
| Other operating expenses | 5007.17M | 4243.04M | 4082.31M | 3645.35M | 3406.58M |
| Interest expense | 612.25M | 602.84M | 574.11M | 467.56M | 440.09M |
| Tax provision | -14.15M | -37.77M | -9.54M | -16.93M | 4.83M |
| Interest income | 607.78M | 613.21M | 560.49M | 439.06M | 435.11M |
| Net interest income | -612.25M | -602.84M | -574.11M | -467.56M | -440.09M |
| Non recurring | - | - | - | -51.58M | -47.32M |
| Income tax expense | -14.15M | -37.77M | -9.54M | -16.93M | 4.83M |
| Total revenue | 5833.98M | 4924.27M | 4497.83M | 4129.19M | 3828.01M |
| Total operating expenses | -1171.03M | 1415.97M | 1521.07M | 1362.43M | 1318.08M |
| Cost of revenue | 6178.20M | 2827.07M | 2561.25M | 2282.92M | 2088.50M |
| Total other income expense net | -579.44M | -630.65M | -455.35M | -511.94M | -327.92M |
| Net income from continuing ops | 261.52M | 88.35M | -30.30M | -40.93M | 56.56M |
| Net income applicable to common shares | 251.38M | 81.15M | -40.97M | -47.45M | 49.01M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 27591.94M | 26186.91M | 24725.43M | 24157.84M | 24717.79M |
| Intangible assets | 10.68M | 11.51M | 5.58M | 1346.19M | 1369.75M |
| Other current assets | 169.45M | 78.01M | 111.16M | 93.07M | -454.86M |
| Total liab | 15006.14M | 15357.31M | 15181.03M | 13936.16M | 13772.03M |
| Total stockholder equity | 12527.25M | 10771.27M | 9488.06M | 10152.97M | 10854.39M |
| Deferred long term liab | - | - | - | 35.57M | 59.26M |
| Other current liab | 147.14M | 146.07M | 126.65M | -321.69M | 10.85M |
| Common stock | 118.73M | 109.12M | 100.65M | 99.91M | 99.84M |
| Capital stock | 118.73M | 109.12M | 100.65M | 99.91M | 99.84M |
| Retained earnings | -7527.78M | -6886.65M | -6213.80M | -5449.39M | -4679.89M |
| Other liab | - | - | - | 127.67M | 59.26M |
| Good will | 1046.07M | 1044.91M | 1045.18M | 1044.41M | 1046.14M |
| Other assets | 23617.00M | 22157.44M | 20863.49M | 20786.80M | 21610.90M |
| Cash | 741.07M | 897.85M | 508.79M | 122.56M | 149.72M |
| Cash and equivalents | 741.07M | 897.85M | 508.79M | 122.56M | 149.72M |
| Total current liabilities | 1387.96M | 1304.77M | 1182.27M | 1148.72M | 1207.71M |
| Current deferred revenue | - | - | -21.66M | 10.49M | -229.85M |
| Net debt | 12478.55M | 12842.70M | 13176.84M | 12792.89M | 12075.05M |
| Short term debt | 0.00M | 6.40M | 14.01M | 428.23M | 336.45M |
| Short long term debt | - | 6.40M | 14.01M | 428.23M | 336.45M |
| Short long term debt total | 13219.62M | 13740.55M | 13685.63M | 12915.45M | 12224.78M |
| Other stockholder equity | 19976.15M | 17582.33M | 15636.97M | 15539.24M | 15498.96M |
| Property plant equipment | 24126.93M | 22600.54M | 21748.95M | 21160.45M | 20447.09M |
| Total current assets | 1326.09M | 1351.53M | 868.20M | 752.71M | 755.12M |
| Long term investments | 718.18M | 721.75M | 678.52M | 22277.47M | 22870.43M |
| Net tangible assets | - | - | - | 9373.20M | 8438.50M |
| Short term investments | - | - | 79.06M | 537.08M | 530.13M |
| Net receivables | 415.57M | 375.68M | 248.25M | 537.08M | 530.13M |
| Long term debt | 13011.02M | 13516.15M | 13476.89M | 12296.78M | 12027.54M |
| Inventory | - | - | - | - | 530.13M |
| Accounts payable | 1240.82M | 1152.31M | 1041.62M | 1031.69M | 1090.25M |
| Noncontrolling interest in consolidated entity | - | - | - | 68.71M | 91.38M |
| Accumulated other comprehensive income | -7567.63M | -6920.18M | -6249.56M | -36.80M | -64.52M |
| Common stock total equity | - | - | - | 99.91M | 99.84M |
| Retained earnings total equity | - | - | - | -5449.39M | -4679.89M |
| Treasury stock | - | - | - | -0.54M | - |
| Non currrent assets other | 24488.12M | 23055.27M | 22126.20M | 20113.78M | 565.07M |
| Non current assets total | 26265.85M | 24835.37M | 23857.24M | 23405.13M | 23962.66M |
| Capital lease obligations | 208.60M | 218.00M | 194.73M | 190.44M | 197.23M |
| Long term debt total | 13011.02M | 11736.30M | 13490.90M | 12296.78M | 12027.54M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -2377.09M | -275.29M | -113.46M | -111.44M |
| Change to liabilities | - | - | - | 12.11M | 16.72M |
| Total cashflows from investing activities | -2730.09M | -2392.82M | -239.20M | -859.22M | -724.14M |
| Net borrowings | -656.03M | 285.01M | 139.59M | 468.80M | -420.79M |
| Total cash from financing activities | 875.73M | 1452.58M | -563.88M | -283.93M | -558.47M |
| Change to operating activities | - | - | - | -47.98M | -60.49M |
| Net income | 251.38M | 81.15M | -40.97M | -40.93M | 56.56M |
| Change in cash | -171.10M | 393.77M | 392.72M | -25.85M | -255.04M |
| Begin period cash flow | 957.23M | 563.46M | 170.75M | 196.60M | 451.64M |
| End period cash flow | 786.14M | 957.23M | 563.46M | 170.75M | 196.60M |
| Total cash from operating activities | 1680.43M | 1337.99M | 1194.54M | 1120.16M | 1026.12M |
| Issuance of capital stock | 2343.69M | 1964.87M | 108.45M | 0.00M | 617.44M |
| Depreciation | 1282.94M | 1167.14M | 1165.86M | 1210.76M | 1215.11M |
| Other cashflows from investing activities | 5.01M | 3.54M | 17.58M | -67.19M | 1.28M |
| Dividends paid | 860.06M | 740.33M | 723.56M | 720.32M | 686.89M |
| Sale purchase of stock | 2454.55M | 1990.92M | 41.84M | -19.75M | -0.10M |
| Other cashflows from financing activities | -45.94M | -44.73M | -47.13M | 1038.96M | 1620.70M |
| Change to netincome | - | - | - | 83.80M | -105.44M |
| Capital expenditures | 363.86M | 281.61M | 259.42M | 454.07M | 432.97M |
| Cash flows other operating | - | - | - | -145.57M | -146.04M |
| Cash and cash equivalents changes | - | - | - | -22.98M | -256.49M |
| Change in working capital | 49.43M | 43.81M | -53.60M | -40.78M | -43.77M |
| Stock based compensation | 38.73M | 30.99M | 30.99M | 30.71M | 31.97M |
| Other non cash items | 96.67M | 45.89M | 123.25M | -18.24M | -232.53M |
| Free cash flow | 1316.56M | 1056.38M | 935.13M | 666.09M | 593.15M |
Sector: Real Estate Industry: REIT - Healthcare Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| VTR Ventas Inc |
-0.16 0.18% |
89.04 | 161.02 | 131.58 | 7.08 | 3.12 | 9.07 | 24.46 |
| WELL Welltower Inc |
-2.56 1.03% |
245.43 | 170.68 | 72.46 | 7.75 | 2.13 | 9.77 | 27.67 |
| OHI Omega Healthcare Investors Inc |
- -% |
47.99 | 16.83 | 10.13 | 11.78 | 2.66 | 14.30 | 12.72 |
| DOC Healthpeak Properties Inc |
-0.05 0.25% |
20.12 | 164.70 | 113.64 | 4.06 | 1.58 | 7.64 | 13.08 |
| AHR American Healthcare REIT, Inc. |
-0.33 0.59% |
56.04 | 117.90 | 61.73 | 4.21 | 2.90 | 4.96 | 31.16 |
Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas, Inc. is based in Illinois, Chicago. Ventas, Inc. was incorporated in 1983 in Maryland.
300 North LaSalle Street, Chicago, IL, United States, 60654
877 483 6827
542
| Name | Title | Year Born |
|---|---|---|
| Ms. Debra A. Cafaro | Chairman & CEO | 1958 |
| Mr. Robert F. Probst | Exec. VP & CFO | 1968 |
| Mr. John D. Cobb | Exec. VP & Chief Investment Officer | 1971 |
| Mr. Peter J. Bulgarelli | Exec. VP of Office | 1961 |
| Mr. J. Justin Hutchens | Exec. VP of Sr. Housing | 1975 |
| Mr. Gregory R. Liebbe | Sr. VP, Chief Accounting Officer & Controller | NA |
| Ms. Bhavana Devulapally | Sr. VP & Chief Information Officer | NA |
| Ms. Carey Shea Roberts J.D. | Exec. VP, Gen. Counsel, Corp. Sec. and Ethics & Compliance Officer | 1971 |
| Ms. Louise Adhikari | VP of Marketing & Corp. Communications | NA |
| Mr. Edmund M. Brady III | Chief HR Officer & Sr. VP | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.